Polymorphism of clinical manifestations, experience of diagnosis and treatment of multisystem inflammatory syndrome associated with COVID-19 in children
DOI:
https://doi.org/10.15574/SP.2022.128.37Keywords:
PIMS-TS, COVID-19, SARS-CoV-2, MIS-C, childrenAbstract
Purpose - to analyze the literature data on possible variants of the course of pediatric multisystem inflammatory syndrome (PIMS-TS) in children; to describe our own experience in the diagnosis and treatment of some cases of PIMS-TS in children of different age groups; to present possible variants of clinical manifestations of the above disease; to draw attention to the need for early diagnosis and team care and treatment of such children.
This novel clinical syndrome later identified as PIMS-TS temporally associated with SARS-CoV-2. In contrast with KD, PIMS-TS appears to occur in children at an older age with a predominance of gastrointestinal symptoms, hemodynamic instability, and myocardial dysfunction. However, the exact pathomechanism remains to be understood. Nevertheless, the post-viral immunological reaction is postulated to be the underlying mechanistic underpinnings.
The paper describes the clinical course of the disease in a 5-year-old boy who complained of abdominal pain and hyperthermia, and the disease was masked by surgical pathology. The phenomena of intoxication syndrome, polyserositis, skin manifestations in the form of a polymorphic rash, hyperemia of the conjunctiva, swelling of the feet and hands increased in dynamics. The course of the disease in a 10-year-old girl who had symptoms of a viral infection is also described. However, upon going to the hospital, both children were diagnosed with a serious condition, they were hospitalized and given appropriate treatment.
Therefore, the multifaceted nature of the PIMS-TS’ course underlines the need for early recognition and multispecialty care and management.
The research was carried out in accordance with the principles of the Helsinki Declaration. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
References
Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S et al. (2020). Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. URL: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.048360. https://doi.org/10.1161/CIRCULATIONAHA.120.048360; PMid:32418446
Blondiaux E, Parisot P, Redheuil A, Tzaroukian L, LevyY, Sileo C et al. (2020). Cardiac MRI of children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19: case series. Radiology. 297: 3. https://doi.org/10.1148/radiol.2020202288; PMid:32515676 PMCid:PMC7294821
Cabrero-Hernández M, García-Salido A, Leoz-GordilloI, Alonso-Cadenas JA, Gochi-Valdovinos A, González Brabin A et al. (2020). Severe SARS-CoV-2 infection in children with suspected acute abdomen: a caseseries from a tertiary hospitalin Spain. Pediatr Infect Dis J. 39 (8): e195-198. https://doi.org/10.1097/INF.0000000000002777; PMid:32467457
Canadian Paediatric Society. (2020). Paediatric inflammatory multisystem syndrom etemporally associated with COVID-19| Canadian Paediatric Society. ULR: https://www.cps.ca/en/documents/position/pims. Accessed 5 Aug 2020.
Capone CA, Subramony A, Sweberg T, Schneider J, Shah S, Rubin L et al. (2020). Characteristics, cardiac in volvement, and outcomes of multisystem inflammatory disease of childhood (MIS-C) associated with SARS-CoV-2 infection. J Pediatr. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293762/. Accessed 20 Jul 2020. https://doi.org/10.1016/j.jpeds.2020.06.044; PMid:32553873 PMCid:PMC7293762
Centers for Disease Control and Prevention. (2020). Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). URL: https://emergency.cdc.gov/han/2020/han00432.asp. Accessed 20 Jul 2020.
Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS et al. (2020). Multisystem inflammatory syndrome related to COVID 19 in previously healthy children and adolescents in New York City. JAMA. 324 (3): 294-296. https://doi.org/10.1001/jama.2020.10374; PMid:32511676 PMCid:PMC7281352
Dasgupta K, Finch SE. (2020). A case of pediatric multisystem inflammatory syndrome temporally associated with COVID-19 in South Dakota. S D Med. 73 (6): 246-251.
Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G et al. (2020). Intensive care admissions of children with paediatric inflammatory multisystem syndrom etemporally associated with SARS-CoV-2 (PIMS-TS) in the UK: amulticentre observational study. Lancet Child Adolesc Health. 4 (9): 669-677. https://doi.org/10.1016/S2352-4642(20)30215-7; PMid:32653054
European Centre for Disease Prevention and Control. (2020). Rapid risk assessment: Paediatric inflammatory multisystem syndromeand SARS-CoV-2 infectionin children. URL: https://www.ecdc.europa.eu/en/publications-data/paediatric-inflammatory-multisystem-syndrome-and-sars-cov-2-rapid-risk-assessment.
Giudicessi JR, Roden DM, Wilde AAM, Ackerman MJ. (2020). Genetic susceptibility for COVID-19 associated sudden cardiac death in African Americans. Heart Rhythm. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198426/. Accessed 29 Jul 2020.
https://doi.org/10.1016/j.hrthm.2020.04.045
PMid:32380288 PMCid:PMC7198426
Greene AG, Saleh M, Roseman E, Sinert R. (2020). Toxic shock-like syndrome and COVID-19: a case report of multisystem inflammatory syndrome in children (MIS-C). Am J Emerg Med. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274960/. Accessed 29 Jul 2020.
Grimaud M, Starck J, Levy M, Marais C, Chareyre J, Khraiche D et al. (2020). Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care. 10 (1): 69. https://doi.org/10.1186/s13613-020-00690-8; PMid:32488505 PMCid:PMC7266128
Harada M, Yokouchi Y, Oharaseki T, Matsui K, Tobayama H, Tanaka N et al. (2012). Histopathological characteristics of myocarditis in acute-phase Kawasaki disease. Histopathology. 61 (6): 1156-1167. https://doi.org/10.1111/j.1365-2559.2012.04332.x; PMid:23134515
Kaushik S, Aydin SI, Derespina KR, Bansal PB, Kowalsky S, Trachtman R et al. (2020). Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection: a multi-institutional study from NewYork City. J Pediatr. 224: 24-29. https://doi.org/10.1016/j.jpeds.2020.06.045; PMid:32553861 PMCid:PMC7293760
Kramaryov SO, Seryakova IYu, Yevtushenko VV, Kaminska TM. (2022). Comparative characteristics of the third wave of coronavirus disease in children with previous outbreaks. Modern Pediatrics. Ukraine. 4 (124): 5-14. https://doi.org/10.15574/SP.2022.124.5
Lawrensia Sh, Henrina J, Wijaya E, Suciadi PL, Saboe A, Cool ChJ. (2020). Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: a New Challenge amid the Pandemic. Springer Nature Switzerland AG 2020. Accepted: 15 October 2020. https://doi.org/10.1007/s42399-020-00602-8; PMid:33106783 PMCid:PMC7578591
Ng KF, Kothari T, Bandi S, Bird PW, Goyal K, Zoha M et al. (2020). COVID-19 multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection. J Med Virol. URL: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26206. https://doi.org/10.1002/jmv.26206; PMid:32568434 PMCid:PMC7362099
Okhotnikova OM, Ivanova TP, Oshlyanskaya OA, Ponochevnaya OV et al. (2020). Treatment protocol of coronavirus infection (COVID-19) in children with chronic somatic diseases. Modern Pediatrics. Ukraine. 4 (108): 18-32. https://doi.org/10.15574/SP.2020.108.18
Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N et al. (2020). Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis. 79 (8): 999-1006. https://doi.org/10.1136/annrheumdis-2020-217960; PMid:32527868 PMCid:PMC7299653
Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG et al. (2020). Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol: 1-11. https://doi.org/10.1007/s00246-020-02391-2; PMid:32529358 PMCid:PMC7289638
Rauf A, Vijayan A, John ST, Krishnan R, Latheef A. (2020). Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic. Indian J Pediatr. https://doi.org/10.1007/s12098-020-03357-1; PMid:32462354 PMCid:PMC8823324
RCPCH. (2020). Royal College of Paediatrics and Child Health Guidance: Paediatric multisystem inflammatory syndrome temporally associated with COVID-19. URL: https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims. Accessed 20 Jul 2020.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. (2020). Hyperinflammatory shock in children during COVID-19 pandemic. Lancet Lond Engl. 395 (10237): 1607-1608. https://doi.org/10.1016/S0140-6736(20)31094-1; PMid:32386565
Rowley AH. (2020). Understanding SARS-CoV-2-related multisystem inflammatory syndromein children. Nat Rev Immunol. 20 (8): 453-454. https://doi.org/10.1038/s41577-020-0367-5; PMid:32546853 PMCid:PMC7296515
Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F et al. (2020). Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ: 369. URL: https://www.bmj.com/content/369/bmj.m2094. Accessed 20 Jul 2020. https://doi.org/10.1136/bmj.m2094; PMid:32493739 PMCid:PMC7500538
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al. (2020). An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV- 2epidemic: an observational cohort study. Lancet. 395 (10239): 1771-1778. https://doi.org/10.1016/S0140-6736(20)31103-X; PMid:32410760
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P et al. (2020). Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 324 (3): 259-269. https://doi.org/10.1001/jama.2020.10369; PMid:32511692 PMCid:PMC7281356
World Health Organization. (2020). Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. URL: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.
World Health Organization. (2020, Sep 14). Coronavirus disease (COVID-19) situation reports 190. URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed 14 Sept 2020.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
